Fuan Pharmaceutical's subsidiary has received the drug registration certificate for Alpha-Lipoic Acid Tablets
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Fuan Pharmaceutical announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Yantai Zhichu Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhichu Pharmaceutical") recently received a drug registration certificate issued by the National Medical Products Administration, involving the product: Alpha-Lipoic Acid Tablets. The indication for Alpha-Lipoic Acid Tablets is: used for sensory abnormalities caused by diabetic peripheral neuropathy
According to the Zhitong Finance APP, Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Yantai Zhichu Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhichu Pharmaceutical") recently received a drug registration certificate issued by the National Medical Products Administration, involving the product: Alpha-Lipoic Acid Tablets. The indication for Alpha-Lipoic Acid Tablets is: for the treatment of sensory abnormalities caused by diabetic peripheral neuropathy